Korea has emerged as a strong player in the global pharmaceutical landscape. The Korean pharmaceutical industry not only holds a huge R&D pipeline, but also possesses a strong portfolio of stringent regulatory authority (SRA) approvals – an interesting market for European companies.
Could Korea be the next market for your pharmaceutical product? Are you curious to learn why they are interested in Basel and what are their goals here?
Join us for an exceptional opportunity of networking with three Korean pharmaceutical companies, all among the top ten in their country: Ildong Pharmaceutical, Daewoong Pharmaceutical and Yuhan Corporation. To save you a trip to Seoul, we have invited the companies to Basel.
Our three guests will introduce their companies, their partnering strategies, and areas of interest. Connect with our speakers and find out how you can collaborate with them!
This event is empowered by Innosuisse.